These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 18316821

  • 1. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD, Laine L, Hughes S, Nicholson A, Galloway A, Gould FK.
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [Abstract] [Full Text] [Related]

  • 2. A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients.
    Laine L, Perry JD, Lee J, Oliver M, James AL, De La Foata C, Halimi D, Orenga S, Galloway A, Gould FK.
    J Cyst Fibros; 2009 Mar; 8(2):143-9. PubMed ID: 19097827
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
    Minchella A, Molinari L, Alonso S, Bouziges N, Sotto A, Lavigne JP.
    Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
    [Abstract] [Full Text] [Related]

  • 11. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: second national study (2003).
    Sánchez-Romero I, Cercenado E, Cuevas O, García-Escribano N, García-Martínez J, Bouza E, Spanish Group for Study of Pseudomonas aeruginosa.
    Rev Esp Quimioter; 2007 Jun; 20(2):222-9. PubMed ID: 17893760
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R, Valdezate S, Vindel A, Sánchez Del Saz B, Maíz L, Baquero F.
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [Abstract] [Full Text] [Related]

  • 14. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis.
    Zebouh M, Thomas C, Honderlick P, Lemee L, Segonds C, Wallet F, Husson MO.
    J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M, Schmoldt S, Götzfried M, Adler K, Heesemann J.
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [Abstract] [Full Text] [Related]

  • 17. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R, Champion A, Reid DW.
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility of Pseudomonas aeruginosa before and after initiation of inhaled tobramycin in Bulgaria.
    Petrova G, Strateva T, Miteva D, Lazova S, Perenovska P.
    J Infect Dev Ctries; 2016 Nov 24; 10(11):1265-1267. PubMed ID: 27886041
    [Abstract] [Full Text] [Related]

  • 19. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H.
    Mikrobiyol Bul; 2008 Apr 24; 42(2):321-9. PubMed ID: 18697430
    [Abstract] [Full Text] [Related]

  • 20. Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index.
    Milne KE, Gould IM.
    J Antimicrob Chemother; 2010 Jan 24; 65(1):82-90. PubMed ID: 19861334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.